pioglitazone has been researched along with aldosterone in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amiri, F; Cohn, JS; Diep, QN; El Mabrouk, M; Endemann, D; Neves, MF; Schiffrin, EL; Virdis, A | 1 |
| Brunner, HR; Burnier, M; Chiolero, A; Maillard, M; Nussberger, J; Zanchi, A | 1 |
| Eguchi, K; Fukuda, T; Hoshide, S; Ishikawa, J; Kario, K; Numao, T; Shimada, K; Tomizawa, H | 1 |
| Akagami, T; Doi, T; Masuyama, T; Mori, Y; Naka, T; Ohyanagi, M; Sakoda, T; Tsujino, T | 1 |
| Boomsma, F; de Boer, RA; Kuipers, I; Martens, FM; Visseren, FL | 1 |
| Akahira, J; Hui, XG; Ito, S; Kudo, M; Matsuda, K; Nakamura, Y; Noguchi, N; Okamoto, H; Rainey, WE; Sasano, H; Satoh, F; Sugawara, A; Uruno, A; Yoshikawa, T | 1 |
| Harada, E; Kashiwagi, Y; Mizuno, Y; Morita, S; Shono, M; Yano, M; Yasue, H; Yoshimura, M | 1 |
| Bollag, WB; Chen, X; Choudhary, V; Olala, L; Pan, ZQ; Seremwe, M; Tsai, YY; Xie, D | 1 |
| Fujiwara, I; Ito, R; Ito, S; Kagechika, H; Kure, S; Noro, E; Parvin, R; Rainey, WE; Saito-Hakoda, A; Shimada, H; Shimizu, K; Sugawara, A; Suzuki, D; Suzuki, S; Yokoyama, A | 1 |
3 trial(s) available for pioglitazone and aldosterone
| Article | Year |
|---|---|
Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Diet, Sodium-Restricted; Humans; Hypoglycemic Agents; Male; Pioglitazone; Placebos; Receptors, Cytoplasmic and Nuclear; Renal Circulation; Renin; Sodium Chloride; Thiazolidinediones; Transcription Factors | 2004 |
Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.
Topics: Adiponectin; Aged; Aldosterone; Biomarkers; Blood Glucose; Cross-Over Studies; Diabetes Mellitus; Fasting; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Middle Aged; Pioglitazone; Thiazolidinediones; von Willebrand Factor | 2007 |
The effects of the PPAR-gamma agonist pioglitazone on plasma concentrations of circulating vasoactive factors in type II diabetes mellitus.
Topics: Aldosterone; Amine Oxidase (Copper-Containing); Atrial Natriuretic Factor; Cross-Over Studies; Diabetes Mellitus, Type 2; Endothelins; Humans; Hypoglycemic Agents; Pioglitazone; PPAR gamma; Renin; Thiazolidinediones | 2010 |
6 other study(ies) available for pioglitazone and aldosterone
| Article | Year |
|---|---|
Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Blood Vessels; Body Weight; Cell Cycle Proteins; Cell Division; Collagen; DNA; Drug Administration Schedule; Endothelium, Vascular; In Vitro Techniques; Inflammation; Injections, Subcutaneous; Lipids; Male; NF-kappa B; Pioglitazone; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Receptors, Cytoplasmic and Nuclear; Renin; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Vascular Cell Adhesion Molecule-1; Vasoconstrictor Agents; Vasodilator Agents | 2002 |
Aldosterone induces interleukin-18 through endothelin-1, angiotensin II, Rho/Rho-kinase, and PPARs in cardiomyocytes.
Topics: Aldosterone; Angiotensin II; Animals; Animals, Newborn; Bezafibrate; Cells, Cultured; DNA Primers; Dose-Response Relationship, Drug; Endothelin-1; Interleukin-18; Myocytes, Cardiac; NF-kappa B; Oligopeptides; Peptides, Cyclic; Peroxisome Proliferator-Activated Receptors; Pioglitazone; Piperidines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Thiazolidinediones | 2008 |
Peroxisome proliferator-activated receptor-{gamma} suppresses CYP11B2 expression and aldosterone production.
Topics: Adrenal Cortex; Aldosterone; Benzophenones; Benzylamines; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinase Type 1; Cell Line; Cytochrome P-450 CYP11B2; Gene Expression; Gene Expression Regulation, Enzymologic; Humans; Ionomycin; Mutation; Pioglitazone; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Sulfonamides; Thiazolidinediones; Transcription, Genetic; Tyrosine; Zona Glomerulosa | 2011 |
Suppression of primary aldosteronism and resistant hypertension by the peroxisome proliferator-activated receptor gamma agonist pioglitazone.
Topics: Aldosterone; Blood Pressure; Comorbidity; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Pioglitazone; PPAR gamma; Thiazolidinediones; Treatment Outcome | 2013 |
The effect of pioglitazone on aldosterone and cortisol production in HAC15 human adrenocortical carcinoma cells.
Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Anilides; Cell Line, Tumor; Cytochrome P-450 CYP11B2; Drug Combinations; eIF-2 Kinase; Fatty Acids; Gene Expression Regulation; Humans; Hydrocortisone; Phosphorylation; Pioglitazone; PPAR gamma; Protein Biosynthesis; RNA, Messenger; Signal Transduction; Thiazolidinediones; Transcription Factor CHOP | 2014 |
Suppressive effects of RXR agonist PA024 on adrenal CYP11B2 expression, aldosterone secretion and blood pressure.
Topics: 2-Naphthylamine; Adrenal Cortex; Aldosterone; Animals; Apoptosis; Blood Pressure; Body Weight; Calcium; Cell Line, Tumor; Cell Proliferation; Cytochrome P-450 CYP11B2; Heart Rate; Humans; Hydrocortisone; Ions; Mice, Transgenic; Nuclear Receptor Subfamily 4, Group A, Member 2; Pioglitazone; Point Mutation; Promoter Regions, Genetic; Pyrimidines; Retinoid X Receptors; RNA, Messenger; Sequence Deletion; Steroids; Thiazolidinediones | 2017 |